trial · primary record
Shingrix
Herpes Zoster
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 135 |
| Primary completion | 2027-01 |
| Primary endpoint | Geometric Mean Fold Rise (GMFR) of Anti-VZV gE Antibody |
| Registry ID | NCT07481604 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:09.172Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07481604
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.